Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 76

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 76
---
 affect our network of medical facilities. If the products provided by NewGenIvf’s suppliers are defective,
of poor quality or are otherwise unsafe or ineffective, the medical facilities in NewGenIvf’s network could be subject to liability
claims, complaints or adverse publicity, any of which would materially and adversely affect its results of operations and reputation.
NewGenIvf cannot assure you that the medical facilities in NewGenIvf’s network will find suitable replacement suppliers on commercially
acceptable terms or at all.

The suppliers are also subject
to extensive laws, rules and regulations. If any suppliers violate applicable laws, rules and regulations, NewGenIvf’s reputation
or procurement may be materially and adversely affected. In addition, the medical facilities in NewGenIvf’s network may be exposed
to reputational damages or even liabilities for defective goods provided by the suppliers or negative publicity associated with any suppliers,
and the business and results of operations of the medical facilities in NewGenIvf’s network and NewGenIvf could suffer as a result.

Independent sub-contractors
and/or agents that work with NewGenIvf are also subject to extensive laws, rules, and regulations. If any sub-contractor and/or agent
violates any applicable laws, rules, regulations or breaches any agreements, NewGenIvf’s reputation may be materially and adversely
affected and NewGenIvf may be penalized by regulatory or other parties. In addition, NewgenIvf’s clients may engage Newgen’s
sub-contractors and/or agents for ongoing services or additional services following the termination of contracts with NewGenIvf. NewGenIvf
has no control over the services provided by sub-contractors and cannot assure the quality of such services or ensure compliance with
applicable laws, rules and regulations. In addition, the services provided by independent sub-contractors may expose NewGenIvf to public
scrutiny, adversely affect its brand and reputation, expose it to litigation or regulatory action, and otherwise make its operations
vulnerable if such independent sub-contractors fail to meet their contractual obligations or to comply with applicable laws or regulations.

If NewGenIvf loses its relationship with one or more key pharmaceutical manufacturers, its business and results of operations could be adversely affected.

NewGenIvf maintains contractual
relationships with select pharmaceutical manufacturers in Thailand, Cambodia and Kyrgyzstan. The consolidation of pharmaceutical manufacturers,
the shortages of drugs provided by such manufacturers, the termination or material alteration of its contractual relationships, or its